ProQR Therapeutics (PRQR) Stock Chart & Stock Price History $2.29 +0.04 (+1.78%) Closing price 04:00 PM EasternExtended Trading$2.34 +0.05 (+2.36%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ProQR Therapeutics Stock Price Performance The ProQR Therapeutics (PRQR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 13.37%, with a year-to-date return of -13.58%. In the past month, the stock has increased 10.10%, reflecting recent market activity. As of the latest close, ProQR Therapeutics traded at $2.25 with a market cap of $236.73 million and volume of 152,458 shares. Five years ago, the stock traded at $5.59, representing a 59.03% decrease over that period. At the time, it had a market cap of $313.40 million and a volume of 215,009 shares. Receive PRQR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+4.57%1 Month Performance+10.10%3 Month Performance+28.65%Year-To-Date Performance-13.58%1 Year Performance+13.37%5 Year Performance-59.03% PRQR Stock Chart for Tuesday, September, 2, 2025 PRQR Chart by TradingView ProQR Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/02/2025$2.25$2.29+1.78%$2.33$2.22446,805 shs$240.93 million09/01/2025$2.25$2.25$2.25$2.13152,458 shs$236.73 million08/29/2025$2.19$2.25+2.74%$2.25$2.13152,458 shs$236.73 million08/28/2025$2.21$2.19-0.90%$2.27$2.19425,892 shs$230.41 million08/27/2025$2.20$2.21+0.45%$2.27$2.18276,743 shs$232.51 million08/26/2025$2.25$2.20-2.22%$2.29$2.19396,635 shs$231.47 million08/25/2025$2.26$2.25-0.44%$2.29$2.22349,594 shs$236.72 million08/22/2025$2.21$2.26+2.26%$2.33$2.16460,691 shs$237.78 million08/21/2025$2.14$2.21+3.27%$2.23$2.10234,775 shs$232.51 million08/20/2025$2.03$2.14+5.42%$2.27$2.01508,370 shs$225.16 million Get the Latest News and Ratings for PRQR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/19/2025$2.12$2.03-4.25%$2.14$1.98359,678 shs$213.58 million08/18/2025$2.05$2.12+3.41%$2.13$1.99485,995 shs$223.05 million08/15/2025$2.02$2.05+1.49%$2.06$2.00124,827 shs$215.68 million08/14/2025$2.02$2.02$2.04$1.96116,605 shs$212.52 million08/13/2025$1.91$2.02+5.76%$2.09$1.92248,658 shs$212.53 million08/12/2025$1.89$1.91+1.06%$2.01$1.80450,754 shs$200.95 million08/11/2025$2.17$1.89-12.90%$2.11$1.85684,660 shs$198.85 million08/08/2025$2.05$2.17+5.85%$2.19$2.03312,555 shs$228.31 million08/07/2025$2.06$2.05-0.49%$2.11$2.02308,845 shs$215.69 million08/06/2025$2.12$2.06-2.83%$2.15$2.01117,443 shs$216.73 million08/05/2025$2.07$2.12+2.42%$2.15$2.01172,050 shs$223.05 million08/04/2025$2.08$2.07-0.48%$2.14$2.01197,460 shs$217.79 million08/01/2025$2.10$2.08-0.95%$2.13$2.04139,878 shs$218.84 million Related Companies Upstream Bio Stock Chart Oric Pharmaceuticals Stock Chart Pharming Group Stock Chart Trevi Therapeutics Stock Chart Urogen Pharma Stock Chart Immunome Stock Chart uniQure Stock Chart Sana Biotechnology Stock Chart Akebia Therapeutics Stock Chart Phathom Pharmaceuticals Stock Chart Receive PRQR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRQR) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProQR Therapeutics N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProQR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
